Table 4.
Ovarian cancer specific mortality | All-cause mortality | ||||
---|---|---|---|---|---|
Total cases, n | Deaths, n | HR (95% CI) | Deaths, n | HR (95% CI) | |
EDIP score | |||||
Low–Low | 257 | 132 | ref | 157 | ref |
Low–High | 98 | 54 | 1.38 (0.99–1.92) | 66 | 1.44 (1.06–1.95) |
High–Low | 98 | 45 | 1.07 (0.71–1.61) | 57 | 1.16 (0.79–1.68) |
High–High | 257 | 138 | 1.58 (1.09–2.30) | 166 | 1.55 (1.10–2.19) |
AHEI | |||||
Low–Low | 229 | 117 | ref | 142 | ref |
Low–High | 81 | 37 | 1.04 (0.71–1.53) | 41 | 0.97 (0.68–1.39) |
High–Low | 81 | 43 | 0.92 (0.60–1.43) | 52 | 0.89 (0.60–1.32) |
High–High | 230 | 116 | 1.10 (0.71–1.70) | 143 | 1.08 (0.73–1.60) |
EDIP score and AHEI were dichotomized at the median. Low–Low, the reference category, represents participants who persistently consumed low EDIP score diet or AHEI (below the median) from pre- to post-diagnosis period.
Models were adjusted for age at diagnosis, calendar year at diagnosis, histology, stage, smoking status, body mass index (<25, 25–29, 30+), total energy intake, nonsteroidal anti-inflammatory drug (NSAID) use, pre-diagnosis cumulative average EDIP score or AHEI.
AHEI alternative healthy eating index, CI confidence interval, EDIP empirical dietary inflammatory pattern score, HR hazard ratio, NHS Nurses’ Health Study, NHSII Nurses’ Health Study II, p-het p-heterogeneity.